-
Medical journals
- Career
Metabolic bone diseases and diabetes
Authors: P. Řehořková
Authors‘ workplace: Endokrinologická ambulance, Hradec Králové
Published in: Vnitř Lék 2006; 52(5): 485-487
Category: Diabetes and other subjects (infection, dermatovenerology and rheumatology) Hradec Králové 3 to 4 June 2005
Overview
Generalized osteoporosis, as one of the metabolic bone diseases, is often diagnosed in diabetics as late as after their first fracture. Alterations of bone metabolism should be therefore taken into account also in early stages of the basic disease. The risk of osteoporosis development is relatively high even in younger age groups of type 1 diabetics who suffer from defect of bone regeneration. In type 2 diabetics, the fractures are predominantly caused by more frequent falls and alterations of bone quality with normal or higher bone density. Therapy of osteoporosis in diabetics should include specific treatment regimes, supplementation with vitamin D and calcium, or an active antiosteoporotic therapy treating the basic disease.
Key words:
diabetes mellitus – osteoporosis – bone mineral density – peak bone mass – osteoblasts
Sources
1. Brown SA, Sharpless JL. Osteoporosis: An under-appreciated complication of diabetes. Clin Diab 2004; 22 : 10-20.
2. Hadjidakis DJ et al. Diabetes and premature menopause: is their co-existence detrimental to the skeleton? EJE 2005; 152 : 437-442.
3. Roman DA et al. Effects of dietary intake and life style on bone density in patients with diabetes mellitus type 2. Ann Nutr Metab 2004; 48 : 142-145.
4. Isaia G et al. High prevalence of hypovitaminosis D in female type 2 diabetic population. Diab Care 2001; 24 : 1496.
5. Harris SS. Vitamin D in type 1 diabetes prevention. J Nutr 2005; 135 : 323-325.
Labels
Diabetology Endocrinology Internal medicine
Article was published inInternal Medicine
2006 Issue 5-
All articles in this issue
- The Nosocomial Infections and Diabetes
- Diabetes mellitus and immunization
- A role of diabetologist in management of infections in diabtics
- Pathogenesis of the connective tissue in diabetes
- Metabolic PPAR receptors and skin
- Diabetic skin changes from the dermatological point of view
- Healing of skin lesions in diabetic foot syndrome during hospitalization
- Infections and diabetic foot syndrome in field practice
- Sodium Hyaluronate and an Iodine Complex - Hyiodine® - New Method of Diabetic Defects Treatment
- Urinary tract infection in patients with diabetes mellitus
- Respiratory infections and inhalation insulin therapy
- Effects of insulin on glucose metabolism in sepsis
- Internist's view on skin manifestations of hyperlipidemia in diabetic patients
- Mycoses and diabetes
- Skin complications of diabetes mellitus therapy
- Diffuse idiopathic skeletal hyperostosis and its relation to metabolic parameters
- Rheumatologic manifestations in diabetes
- Metabolic bone diseases and diabetes
- Gout and diabetes
- Glucocorticoids and diabetes mellitus
- Anagrelide in the treatment of essential thrombocythemia (ET) and other myeloproliferative disorders with thrombocythemia based on data from patient register in the CR
- Internal Medicine
- Journal archive
- Current issue
- Online only
- About the journal
Most read in this issue- Diabetic skin changes from the dermatological point of view
- Glucocorticoids and diabetes mellitus
- Diffuse idiopathic skeletal hyperostosis and its relation to metabolic parameters
- Skin complications of diabetes mellitus therapy
Login#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Career